Rafarma Pharmaceuticals RAFA Stock
Rafarma Pharmaceuticals Price Chart
Rafarma Pharmaceuticals RAFA Financial and Trading Overview
| Rafarma Pharmaceuticals stock price | 0.0089 USD |
| Previous Close | 0.009 USD |
| Open | 0.01 USD |
| Bid | 0.009 USD x 1000000 |
| Ask | 0.01 USD x 1000000 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.004 - 0.09 USD |
| Volume | 62.5K USD |
| Avg. Volume | 19.58K USD |
| Market Cap | 1.05M USD |
| Beta (5Y Monthly) | 0.965 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.014 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RAFA Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.8990498 |
| Price/Book (mrq) | 0.00029639143 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Rafarma Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.965 |
| 52-Week Change | -67.56% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 0.09 USD |
| 52 Week Low | 0.004 USD |
| 50-Day Moving Average | 0.03 USD |
| 200-Day Moving Average | 0.04 USD |
RAFA Share Statistics
| Avg. Volume (3 month) | 19.58K USD |
| Avg. Daily Volume (10-Days) | 65.91K USD |
| Shares Outstanding | 87.77M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2012 |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | March 31, 2013 |
Profitability
| Profit Margin | -87.91% |
| Operating Margin (ttm) | -81.25% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -0.041% |
| Return on Equity (ttm) | -0.071% |
Income Statement
| Revenue (ttm) | 133.33K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 0 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -117223 USD |
| Diluted EPS (ttm) | -0.014 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 40.487 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 25K USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Rafarma Pharmaceuticals
| Country | United States |
| State | UT |
| City | Draper |
| Address | 12465 South Fort St |
| ZIP | 84020 |
| Phone | 307 429 2029 |
| Website | https://rafarma.co |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Rafarma Pharmaceuticals, Inc. engages in the development and production of medical equipment. It is also involved in the supply of equipment for hospitals and clinics. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company was incorporated in 1982 and is based in Draper, Utah. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Q&A For Rafarma Pharmaceuticals Stock
What is a current RAFA stock price?
Rafarma Pharmaceuticals RAFA stock price today per share is 0.0089 USD.
How to purchase Rafarma Pharmaceuticals stock?
You can buy RAFA shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rafarma Pharmaceuticals?
The stock symbol or ticker of Rafarma Pharmaceuticals is RAFA.
Which industry does the Rafarma Pharmaceuticals company belong to?
The Rafarma Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does Rafarma Pharmaceuticals have in circulation?
The max supply of Rafarma Pharmaceuticals shares is 87.77M.
What is Rafarma Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Rafarma Pharmaceuticals PE Ratio is now.
What was Rafarma Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Rafarma Pharmaceuticals EPS is -0.014 USD over the trailing 12 months.
Which sector does the Rafarma Pharmaceuticals company belong to?
The Rafarma Pharmaceuticals sector is Healthcare.


